Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63. (Q39665370)

13 September 2017

Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63. (English)

1 reference

13 September 2017

S-E Chow

1

1 reference

13 September 2017

J-S Wang

2

1 reference

13 September 2017

S-F Chuang

3

1 reference

13 September 2017

Y-L Chang

4

1 reference

13 September 2017

W-K Chu

5

1 reference

13 September 2017

W-S Chen

6

1 reference

13 September 2017

Y-W Chen

7

1 reference

13 September 2017

20 August 2010

1 reference

13 September 2017

1 reference

13 September 2017

17

1 reference

13 September 2017

12

1 reference

13 September 2017

872-882

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2010.44

13 September 2017

0 references

cites work

High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Overexpression of delta Np63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Loss of p63 expression is associated with tumor progression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

p63: oncogene or tumor suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

p63 and p73 in human cancer: defining the network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

One, two, three--p53, p63, p73 and chemosensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

AIS is an oncogene amplified in squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Resveratrol: a review of preclinical studies for human cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Cardiovascular protective effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Resveratrol: from grapevines to mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

A dominant negative form of p63 inhibits apoptosis in a p53-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

p53 associates with and targets Delta Np63 into a protein degradation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Dual regulation of the DeltaNp63 transcriptional activity by DeltaNp63 in human nasopharyngeal carcinoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Principles of tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Positive and negative regulation of ΔN-p63 promoter activity by p53 and ΔN-p63-α contributes to differential regulation of p53 target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Reactive oxygen species: role in the development of cancer and various chronic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Role of reactive oxygen species in apoptosis: implications for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

DeltaNp63alpha levels correlate with clinical tumor response to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

inferred from DOI database lookup

7 January 2021

based on heuristic

The growth-promoting effect of KGF on limbal epithelial cells is mediated by upregulation of DeltaNp63alpha through the p38 pathway

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

inferred from DOI database lookup

7 January 2021

based on heuristic

Resveratrol, a remarkable inhibitor of ribonucleotide reductase

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.44

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2010.44

1 reference

13 September 2017

1 reference